A former teammate pointed Carcillo toward psilocybin and he has since meticulously tracked its effect on him, tweaking the protocol and dosage, and adding other holistic aspects to help his recovery. After months of getting nowhere, he has found himself getting better and he hopes to bring that apparent success to others through Wesana.
For example, Mind Medicine Inc., a Canadian company backed by Shark Tank’s Kevin O’Leary and one-time cannabis power-player Bruce Linton, has a market cap of $1.34 billion, despite not being on a major exchange. Compass Pathways PLC, the first psychedelic drug company to go public on a major U.S. exchange, was trading above US$40 at the end of January on the Nasdaq, for a market cap of US$1.58 billion.
Nevertheless, there’s plenty of buzz in psychedelics, both among investors and researchers, including a team at famed Johns Hopkins Medicine, which in 2019 started the Center for Psychedelic and Consciousness Research. “All of the smaller companies are doing all the hard work on the research and things like that, and they are ultimately the ones that will sell these things to the large drug companies who can’t ignore this space,” Hawkins says.
“This isn’t just something for, no offence, 720 NHL players. This is something that can be extremely meaningful for millions of veterans,” he says. “And for every one NFL concussion, there’s 7,000 amongst women of domestic violence, so these communities can be helped.”
مصر أحدث الأخبار, مصر عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
مصدر: nationalpost - 🏆 10. / 80 اقرأ أكثر »